Hepatitis E Diagnostic Tests Market - Top Companies and Manufacturers

  • Report ID: 6507
  • Published Date: Oct 03, 2024
  • Report Format: PDF, PPT

Companies Dominating the Hepatitis E Diagnostic Tests Market

    Numerous firms have set up initiatives to conduct diagnostic tests for hepatitis E, which is an important public health concern. Companies that deal with hepatitis E diagnostic tests vary with different approaches in conducting the test, which may include serological assays targeting antibodies and molecular tests targeting the identification of the virus's genetic material. Advances in diagnostic technology focus on increasing the efficiency, speed, and accessibility of hepatitis E testing. As awareness about the disease increases, these companies play an important role in promoting early detection and efficient management, further improving healthcare outcomes and surveillance in the infected regions. The prominent players with valuable contributions are:

    • Altona Diagnostic GmbH
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • CTK Biotech, Inc.
    • Dia.Pro Diagnostic Bioprobes s.r.l
    • DiaSorin S.p.A.
    • ELITechGroup (Bruker company)
    • F. Hoffmann-La Roche Ltd
    • Fortress Diagnostic
    • Genscript Biotech Corporation
    • Guangzhou Wondfo Biotech Co., Ltd.
    • Medsource Ozone Biomedicals Pvt. Ltd.
    • MIKROGEN GmbH
    • MP Biomedicals
    • Primer Design
    • Wantai BioPharm

Browse Key Market Insights with Data Illustration:

In the News

  • In November 2023, Roche introduced the automated Elecsys Anti-HEV IgM and Elecsys Anti-HEV IgG immunoassays to identify hepatitis E virus (HEV) infections in nations that accept the CE mark, such as the European Union.
  • In November 2023, the WHO published the 2023 Essential Diagnostic List (EDL) and added the hepatitis E virus (HEV) to this list along with a recommendation to diagnose acute HEV infections, particularly in immunocompromised patients and pregnant women, using nucleic acid tests (NATs) such as PCR assays.

Author Credits:  Radhika Pawar


  • Report ID: 6507
  • Published Date: Oct 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In 2024, the industry size of the hepatitis E diagnostic tests market was over USD 62.9 million.

The market size of the hepatitis E diagnostic tests landscape is projected to surpass USD 106.6 million by the end of 2037 expanding at a CAGR of 4.5% during the forecast period i.e., between 2025-2037.

The major players in the market are Fortress Diagnostic, Genscript Biotech Corporation, Guangzhou Wondfo Biotech Co., Ltd., Medsource Ozone Biomedicals Pvt. Ltd., MIKROGEN GmbH, MP Biomedicals, and others.

In terms of test type, the ELISA HEV IgM segment is anticipated to garner the largest market share of 51.5% by 2037 and display significant growth opportunities during 2025-2037.

The market in North America is projected to hold the largest revenue share of 44.6% by the end of 2037 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample